Perrigo Announces FDA Final Approval Of Betamethasone Valerate FoamPerrigo Co. (Nasdaq: PRGO) Tuesday announced that its partner, Cobrek Pharmaceuticals Inc., received final approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for betamethasone valerate foam 0.12 percent, the generic equivalent of Luxiq Foam.

More From CBS Detroit

Best Places For Paczki In DetroitFat Tuesday is less than a week away! Here's where to find the best paczki in town.
Best Ice Cream Shops In Metro DetroitIt's getting warm outside! Take advantage of it.
Best Hiking Trails In Metro DetroitGet out there and enjoy this unseasonably warm weather!

Watch & Listen